BACKGROUND: The impact of psychosocial research participation has not been examined systematically in palliative care settings. Concerns are often raised regarding the potential for distress among terminally ill patients. This is particularly true when death and dying are the focus of research. Therefore, it is important to understand the specific ways psychosocial research could potentially harm or be helpful to participants. OBJECTIVE: To assess the burden and benefits of participation in psychosocial research addressing end-of-life issues among patients receiving inpatient palliative care. DESIGN: Sixty-eight terminally ill patients with cancer who had an average life expectancy of less than 2 months, were administered a brief self-report questionnaire to assess whether participation in psychosocial research was burdensome and/or beneficial. The specific factors that contributed to their perceptions were also identified. RESULTS: The majority of patients reported no burden associated with participation (75%) and found the experience as moderately to highly beneficial (68%). Factors most frequently identified as burdensome included the length of the interview (21%), structure of the questionnaires (18%), and difficulty discussing end-of life issues (12%). Although some patients reported some distress while discussing end-of-life issues (19%), few endorsed a high level of distress (6%). Factors most frequently identified as beneficial were the social interaction (75%), sense of contributing to society (57%), and the opportunity to discuss their illness (47%). CONCLUSIONS: Participants in psychosocial end-of-life research are unlikely to experience significant burden from participation and, in fact, may benefit.
BACKGROUND: The impact of psychosocial research participation has not been examined systematically in palliative care settings. Concerns are often raised regarding the potential for distress among terminally ill patients. This is particularly true when death and dying are the focus of research. Therefore, it is important to understand the specific ways psychosocial research could potentially harm or be helpful to participants. OBJECTIVE: To assess the burden and benefits of participation in psychosocial research addressing end-of-life issues among patients receiving inpatient palliative care. DESIGN: Sixty-eight terminally ill patients with cancer who had an average life expectancy of less than 2 months, were administered a brief self-report questionnaire to assess whether participation in psychosocial research was burdensome and/or beneficial. The specific factors that contributed to their perceptions were also identified. RESULTS: The majority of patients reported no burden associated with participation (75%) and found the experience as moderately to highly beneficial (68%). Factors most frequently identified as burdensome included the length of the interview (21%), structure of the questionnaires (18%), and difficulty discussing end-of life issues (12%). Although some patients reported some distress while discussing end-of-life issues (19%), few endorsed a high level of distress (6%). Factors most frequently identified as beneficial were the social interaction (75%), sense of contributing to society (57%), and the opportunity to discuss their illness (47%). CONCLUSIONS:Participants in psychosocial end-of-life research are unlikely to experience significant burden from participation and, in fact, may benefit.
Authors: Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart Journal: Psychooncology Date: 2011-07-12 Impact factor: 3.894
Authors: Lisa Sweet; Dimitrios Adamis; David J Meagher; Daniel Davis; David C Currow; Shirley H Bush; Christopher Barnes; Michael Hartwick; Meera Agar; Jessica Simon; William Breitbart; Neil MacDonald; Peter G Lawlor Journal: J Pain Symptom Manage Date: 2013-12-31 Impact factor: 3.612
Authors: Antonella Surbone; Lea Baider; Tammy S Weitzman; Mary Jacqueline Brames; Cynthia N Rittenberg; Judith Johnson Journal: Support Care Cancer Date: 2009-07-17 Impact factor: 3.603
Authors: Leena Nahata; Taylor L Morgan; Keagan G Lipak; Olivia E Clark; Nicholas D Yeager; Sarah H O'Brien; Stacy Whiteside; Anthony N Audino; Cynthia A Gerhardt; Gwendolyn P Quinn Journal: J Assist Reprod Genet Date: 2019-08-01 Impact factor: 3.412
Authors: Meaghann S Weaver; Kim Mooney-Doyle; Katherine Patterson Kelly; Kathleen Montgomery; Amy R Newman; Christine A Fortney; Cynthia J Bell; Jessica L Spruit; Melissa Kurtz Uveges; Lori Wiener; Cynthia M Schmidt; Vanessa N Madrigal; Pamela S Hinds Journal: J Palliat Med Date: 2019-03-05 Impact factor: 2.947
Authors: Thomas M Atkinson; Karen Hurley; Carma L Bylund; Alexandra Berk; Kimberly Diminni; Jamie S Ostroff Journal: J Cancer Educ Date: 2013-03 Impact factor: 2.037